Skip to main content

KAMES CAPITAL plc

Position in GILD — Gilead Sciences, Inc.

CIK 1539994 EDINBURGH, X0

Position in GILD

as of Jun 30, 2026 · filed Jul 13, 2026
Position Value
$24,275,725
-$6,796,259 QoQ
Shares Held
192,146
-13.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#9
of 188 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

KAMES CAPITAL plc holds $1,010,877,249 across 9 Drug Manufacturers - General names. GILD ranks #8 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GILD
Gilead Sciences, Inc.
This page
192,146 $24,275,725

All Filings in GILD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,275,725 192,146
2026-03-31 $31,071,984 222,946
2025-12-31 $27,364,392 222,946
2025-09-30 $27,037,491 243,581
2025-06-30 $28,075,499 253,229
2025-03-31 $32,025,794 285,817
2024-12-31 $24,706,573 267,474
2024-09-30 $21,840,823 260,506
2024-06-30 $18,213,210 265,460
2024-03-31 $21,189,100 289,271
2023-12-31 $63,970,842 789,666
2023-06-30 $87,621,576 1,136,909
2023-03-31 $95,074,659 1,145,892
2022-12-31 $106,587,325 1,241,553
2022-09-30 $79,828,463 1,294,026
2022-06-30 $80,181,539 1,297,226
2022-03-31 $75,717,957 1,273,641
2021-12-31 $73,293,550 1,009,414
2021-09-30 $70,844,524 1,014,238
2021-06-30 $70,454,453 1,023,155
2021-03-31 $71,137,400 1,100,687
2020-12-31 $76,012,812 1,304,717
2020-09-30 $30,473,440 482,251
2020-06-30 $35,301,610 458,820